{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:32Z","timestamp":1791593852423,"version":"4.3.4"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00554","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:30:10Z","timestamp":1591965010000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child"],"prefix":"10.3389","volume":"11","author":[{"given":"Nils Erik","family":"Gilhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Eng J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimm Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMc1611704","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Eng J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ane.12233","article-title":"Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries","volume":"129","author":"Andersen","year":"2014","journal-title":"Acta Neurologica Scandinavica."},{"key":"B6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00415-017-8478-z","article-title":"Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms","volume":"264","author":"Hong","year":"2017","journal-title":"J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2015.04.015","article-title":"MuSK autoantibodies in myasthenia gravis detected by cell based assay - A multinational study","volume":"284","author":"Tsonis","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/mus.24556","article-title":"Impact of myasthenia gravis on family planning: How do women with myasthenia gravis decide and why?","volume":"52","author":"Ohlraun","year":"2015","journal-title":"Muscle Nerve."},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J Autoimm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1212\/WNL.0000000000003339","article-title":"Increased risk for clinical onset of myasthenia gravis during the postpartum period","volume":"87","author":"Boldingh","year":"2016","journal-title":"Neurology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1210\/jc.2014-3588","article-title":"Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a danish population-based study","volume":"100","author":"Andersen","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.beem.2019.101321","article-title":"Exacerbations of autoimmune diseases during pregnancy and postpartum","volume":"33","author":"Borba","year":"2019","journal-title":"Best Prac Res Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0301-2115(02)00051-9","article-title":"Myasthenia gravis in pregnancy: report on 69 cases","volume":"104","author":"Djelmis","year":"2002","journal-title":"Eur J Obst Gynecol Reprod Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.52.3.447","article-title":"Course and treatment of myasthenia gravis during pregnancy","volume":"52","author":"Batocchi","year":"1999","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s11845-019-02029-0","article-title":"Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary center and comparison with previous studies","volume":"188","author":"Tanacan","year":"2019","journal-title":"Irish J Med Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nmd.2017.01.021","article-title":"Clinical follow-up of pregnancy in myasthenia gravis patients","volume":"27","author":"Ducci","year":"2017","journal-title":"Neuromusc Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mus.25095","article-title":"Myasthenia gravis in pregnancy: experience of a portuguese center","volume":"54","author":"Braga","year":"2016","journal-title":"Muscle Nerve."},{"key":"B18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0035-3787(06)75019-6","article-title":"Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase","volume":"162","author":"Ramirez","year":"2006","journal-title":"Revue Neurologique."},{"key":"B19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nmd.2017.11.014","article-title":"MuSK myasthenia gravis and pregnancy","volume":"28","author":"Santos","year":"2018","journal-title":"Neuromusc Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1136\/jnnp-2013-305572","article-title":"Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group","volume":"85","author":"Norwood","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ene.13788","article-title":"Maternal myasthenia gravis represents a risk for the child through autoantibody transfer, immunosuppressive therapy and genetic influence","volume":"2018","author":"Gilhus","year":"2018","journal-title":"Eur J Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/nyas.13537","article-title":"Developing treatment guidelines for myasthenia gravis","volume":"1412","author":"Sanders","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.msard.2019.06.003","article-title":"B cell depletion and pregnancy: review and applications for MS treatment","volume":"33","author":"Shah","year":"2019","journal-title":"Mult Scler Rel Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-016-8586-z","article-title":"Female infertility and serum auto-antibodies: a systematic review","volume":"53","author":"Deroux","year":"2017","journal-title":"Clin Rev Allerg Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/01.WNL.0000082725.21444.EC","article-title":"Myasthenia gravis - consequences for pregnancy, delivery, and the newborn","volume":"61","author":"Hoff","year":"2003","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care","volume":"14","author":"Hoff","year":"2007","journal-title":"Eur J Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/pds.5017","article-title":"Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: a retrospective cohort study","volume":"29","author":"Thai","year":"2020","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"B28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/13625187.2014.990088","article-title":"Preconception care policy, guidelines, recommendations and services across six European countries: Belgium (Flanders), Denmark, Italy, the Netherlands, Sweden and the United Kingdom","volume":"20","author":"Shawe","year":"2015","journal-title":"Eur J Contrac Reprod Health Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1468-1331.2004.00900.x","article-title":"Asymptomatic myasthenia gravis influences pregnancy and birth","volume":"11","author":"Hoff","year":"2004","journal-title":"Eur J Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1468-1331.2009.02689.x","article-title":"No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study","volume":"16","author":"Wen","year":"2009","journal-title":"Eur J Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.15553","article-title":"Relationship between cesarean delivery rate and maternal and neonatal mortality","volume":"314","author":"Molina","year":"2015","journal-title":"JAMA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/jog.13922","article-title":"Management of labor and delivery in myasthenia gravis: a new protocol","volume":"45","author":"Tsurane","year":"2019","journal-title":"J Obstet Gynaecol Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/GRF.0b013e31828e92c0","article-title":"Myasthenia Gravis and Pregnancy","volume":"56","author":"Varner","year":"2013","journal-title":"Clin Obstet Gynecol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E133","DOI":"10.1055\/s-0036-1579624","article-title":"Seronegative maternal ocular myasthenia gravis and delayed transient neonatal myasthenia gravis","volume":"6","author":"Townsel","year":"2016","journal-title":"Ajp Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain."},{"key":"B36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/WCO.0b013e32833c32af","article-title":"Acquired myasthenia gravis in childhood","volume":"23","author":"Evoli","year":"2010","journal-title":"Curr Opin Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1515\/JPM.2008.070","article-title":"Can neonatal myasthenia gravis be predicted?","volume":"36","author":"Gveric-Ahmetasevic","year":"2008","journal-title":"J Perin Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0897.1996.tb00172.x","article-title":"Evolution of maternofetal transport of immunoglobulins during human pregnancy","volume":"36","author":"Malek","year":"1996","journal-title":"Am J Reprod Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1586\/eci.12.99","article-title":"Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy","volume":"9","author":"Malek","year":"2013","journal-title":"Expert Rev Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.c.31723","article-title":"Fetal arthrogryposis: Challenges and perspectives for prenatal detection and management","volume":"181","author":"Filges","year":"2019","journal-title":"Am J Med Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ejogrb.2011.09.027","article-title":"Arthrogryposis multiplexa congenita: an epidemiologic study of nearly 9 million births in 24 EUROCAT registers","volume":"159","author":"Hoff","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/NXI.0000000000000057","article-title":"Fetal acetylcholine receptor inactivation syndrome A myopathy due to maternal antibodies","volume":"2","author":"Hacohen","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1212\/01.wnl.0000278101.95510.09","article-title":"Isolated facial and bulbar paresis: A persistent manifestation of neonatal myasthenia gravis","volume":"70","author":"Jeannet","year":"2008","journal-title":"Neurology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12778","DOI":"10.1111\/aji.12778","article-title":"Breastfeeding and autoimmunity: Programing health from the beginning","volume":"79","author":"Borba","year":"2018","journal-title":"Am J Reprod Immun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/rheumatology\/kex039","article-title":"Low level of Rituximab in human breast milk in a patient treated during lactation","volume":"56","author":"Bragnes","year":"2017","journal-title":"Rheumatology."},{"key":"B46","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1212\/WNL.0000000000008213","article-title":"Navigating monoclonal antibody use in breastfeeding women Do no harm or do little good?","volume":"93","author":"LaHue","year":"2019","journal-title":"Neurology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T12:30:12Z","timestamp":1591965012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":48,"alternative-id":["10.3389\/fneur.2020.00554"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00554","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"article-number":"554"}}